Clinical Trials Directory

Trials / Completed

CompletedNCT05791669

Arrest of Interproximal Caries Lesion With 38% Silver Diamine Fluoride Solution

Arrest of Interproximal Caries Lesion in Primary Molars With 38% Silver Diamine Fluoride Solution and 5% Sodium Fluoride Varnish: A Randomized Clinical Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Postgraduate Institute of Dental Sciences Rohtak · Academic / Other
Sex
All
Age
5 Years – 9 Years
Healthy volunteers
Not accepted

Summary

This study was conducted to assess the efficacy of 38% Silver Diamine fluoride and compare it with 5% sodium fluoride varnish in arresting interproximal caries in primary molars at 12 months follow-up. Bitewing radiographs were taken to diagnose as well as to assess caries depth at follow up visits. Each bitewing was scored based on ICCMS radiographic criteria and was compared (follow-ups to baseline)to check for caries arrest. Interproximal caries included in this study, according to ICCMS criteria, were at stages- RA - caries limited to outer half of enamel RA2 - caries limited to the inner half of enamel RA3 - caries limited to outer third of dentine RA4 - caries limited to middle third of dentine

Conditions

Interventions

TypeNameDescription
DRUGSilver diamine fluorideSilver diamine fluoride is a topical medication composed of 25% silver, 5% fluoride, 8% ammonia, and 62% Deionized water, used to treat and prevent dental caries and relieve dentinal hypersensitivity.
DRUGSodium fluoride varnishIt is a topical application with an active ingredient of 5% sodium fluoride(22,600ppm fluoride).it prolongs the contact time between the fluoride and tooth surface and promotes remineralization and inhibits demineralization.

Timeline

Start date
2021-08-01
Primary completion
2022-08-02
Completion
2022-11-08
First posted
2023-03-30
Last updated
2023-03-30

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT05791669. Inclusion in this directory is not an endorsement.